Prostate Cancer - Results from #27800

Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU) - Abstract June 2, 2011

Preventive care in prostate cancer patients: Following diagnosis and for five-year survivors - Abstract June 2, 2011

The application of natural orifice surgery for adenocarcinoma of the prostate - Abstract June 2, 2011

Clinical application of a 3D ultrasound-guided prostate biopsy system - Abstract June 2, 2011

Characterization of bone metastases from rapid autopsies of prostate cancer patients - Abstract June 2, 2011

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer - Abstract June 2, 2011

Bone metastasis in prostate cancer: Emerging therapeutic strategies - Abstract June 2, 2011

Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration - Abstract June 2, 2011

Knowledge of symptoms and diagnostic possibilities of cancer diseases - Abstract June 1, 2011

Behind closed doors II: Systematic analysis of prostate cancer patients' primary treatment consultations with radiation oncologists and predictors of satisfaction with communication - Abstract June 1, 2011

Retargeting of T cells to prostate stem cell antigen expressing tumor cells: Comparison of different antibody formats - Abstract June 1, 2011

Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer - Abstract June 1, 2011

What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models - Abstract June 1, 2011

Immunotherapy in castration-resistant prostate cancer: Integrating sipuleucel-T into our current treatment paradigm - Abstract June 1, 2011

Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients - Abstract June 1, 2011

The role of abiraterone acetate in the management of prostate cancer: A critical analysis of the literature - Abstract June 1, 2011

High-dose-rate brachytherapy as a monotherapy for favorable-risk prostate cancer: A Phase II trial - Abstract June 1, 2011

Dealing with a troublesome body: A qualitative interview study of men's experiences living with prostate cancer treated with endocrine therapy - Abstract June 1, 2011

Patient-reported outcomes of prostate high-dose-rate brachytherapy boost comparing an outpatient and inpatient protocol: A two-center chronologic cohort study - Abstract June 1, 2011

Editor's Commentary - Acceptance and durability of surveillance as a management choice in men with screen-detected, low-risk prostate cancer: Improved outcomes with stringent enrollment criteria June 1, 2011

Page 1391 of 1436